Topical application of polyhexamethylene biguanide on Acanthamoeba keratitis.

Topical application of polyhexamethylene biguanide on Acanthamoeba keratitis. - Topical application of polyhexamethylene biguanide on Acanthamoeba keratitis.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017019

Enrollment

200

Registered

2015-07-01

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acanthamoeba keratitis

Interventions

Treatment with 0.02% polyhexamethylene biguanide in patients with Acanthamoeba keratitis.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Acanthamoeba keratitis.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Treatment effect of corneal infection and improvement of visual acuity in patients with Acanthamoeba keratitis.	—

Countries

Japan

Contacts

Public ContactYuichi Kaji

Tsukuba Univeristy Ophthalmology

kajiyuichi@gmai.com0298533148

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026